Physician perspectives on the importance of facts men ought to know about prostate-specific antigen testing
- PMID: 12795733
- PMCID: PMC1494865
- DOI: 10.1046/j.1525-1497.2003.20626.x
Physician perspectives on the importance of facts men ought to know about prostate-specific antigen testing
Abstract
Objective: To determine physicians' rating of the importance of key facts men ought to know about prostate-specific antigen (PSA) screening and whether there are differences by specialty.
Participants: A nationwide random sample of internists, family physicians, and urologists stratified by physician specialty from The Official ABMS Directory of Board-Certified Medical Specialists 2000 Edition.
Measurements: Internists (N = 139), family physicians (N = 160), and urologists (N = 151) were asked to rate how important it is for men to know 17 facts about PSA screening using a 5-point Likert scale.
Main results: Of 769 eligible physicians, 450 responded, for an overall response rate of 59%. Urologists and nonurologists differed in rating how important it was for men to know 9 of the 17 key facts. Eight of the nine statements that urologists and nonurologists disagreed upon concerned facts reflecting uncertainty. Nonurologists were more likely than urologists to rate facts reflecting uncertainty as highly important for men to know. These included statements about prostate cancer risk, screening with PSA, and treatment.
Conclusions: Despite professional guidelines supporting informed decision making, the importance of facts men ought to know about PSA testing differ by physician specialty. Systematic differences may reflect differences in professional guidelines about PSA testing.
Comment in
-
Patient-provider communication in cancer screening.J Gen Intern Med. 2003 May;18(5):402-3. doi: 10.1046/j.1525-1497.2003.30346.x. J Gen Intern Med. 2003. PMID: 12795740 Free PMC article. No abstract available.
-
Virtual physicians, health systems, and the healing relationship.J Gen Intern Med. 2003 May;18(5):404-6. doi: 10.1046/j.1525-1497.2003.30348.x. J Gen Intern Med. 2003. PMID: 12795741 Free PMC article. No abstract available.
Similar articles
-
Do Swiss urologists and Swiss internists screen themselves and their relatives for prostate cancer? A questionnaire study.Swiss Med Wkly. 2023 Sep 14;153:40115. doi: 10.57187/smw.2023.40115. Swiss Med Wkly. 2023. PMID: 37774392
-
What should men know about prostate-specific antigen screening before giving informed consent?Am J Med. 1998 Oct;105(4):266-74. doi: 10.1016/s0002-9343(98)00257-5. Am J Med. 1998. PMID: 9809686
-
Brief report: physicians and their personal prostate cancer-screening practices with prostate-specific antigen. A national survey.J Gen Intern Med. 2006 Mar;21(3):257-9. doi: 10.1111/j.1525-1497.2006.00327.x. J Gen Intern Med. 2006. PMID: 16637825 Free PMC article.
-
PSA and the family physician.Can J Urol. 2011 Apr;18 Suppl:20-3. Can J Urol. 2011. PMID: 21501547 Review.
-
[Ocular allergies - useful facts for family doctors].MMW Fortschr Med. 2025 Jun;167(10):64-66. doi: 10.1007/s15006-025-4848-0. MMW Fortschr Med. 2025. PMID: 40467816 Review. German. No abstract available.
Cited by
-
Delivering the unexpected-Information needs for PSA screening from Men's perspective: A qualitative study.Health Expect. 2021 Aug;24(4):1403-1412. doi: 10.1111/hex.13275. Epub 2021 Jun 7. Health Expect. 2021. PMID: 34097797 Free PMC article.
-
Physician-patient discussions about prostate-specific antigen test use among African-American men.J Natl Med Assoc. 2006 Apr;98(4):532-8. J Natl Med Assoc. 2006. PMID: 16623065 Free PMC article.
-
A structured implicit abstraction method to evaluate whether content of counseling before prostate cancer screening is consistent with recommendations by experts.Patient Educ Couns. 2009 Dec;77(3):322-7. doi: 10.1016/j.pec.2009.09.023. Epub 2009 Oct 17. Patient Educ Couns. 2009. PMID: 19837527 Free PMC article.
-
Patient-Provider Communication About Prostate Cancer Screening and Treatment: New Evidence From the Health Information National Trends Survey.Am J Mens Health. 2017 Jan;11(1):134-146. doi: 10.1177/1557988315614082. Epub 2016 Jul 7. Am J Mens Health. 2017. PMID: 26614441 Free PMC article.
-
Do health professionals know about overdiagnosis in screening, and how are they dealing with it? A mixed-methods systematic scoping review.PLoS One. 2025 Feb 3;20(2):e0315247. doi: 10.1371/journal.pone.0315247. eCollection 2025. PLoS One. 2025. PMID: 39899650 Free PMC article.
References
-
- Burack RC, Wood DP., Jr Screening for prostate cancer. The challenge of promoting informed decision making in the absence of definitive evidence of effectiveness. Med Clin North Am. 1999;83:1423–42. - PubMed
-
- Coley CM, Barry MJ, Fleming C, Mulley AG. Early detection of prostate cancer, Part I: prior probability and effectiveness of tests. The American College of Physicians. Ann Intern Med. 1997;126:394–406. - PubMed
-
- Woolf SH. Screening for prostate cancer with prostate-specific antigen: an examination of the evidence. N Engl J Med. 1995;333:1401–5. - PubMed
-
- Gohagan JK, Prorok PC, Kramer BS, Cornett JE. Prostate cancer screening in the prostate, lung, colorectal, and ovarian cancer screening trial of the National Cancer Institute. J Urol. 1994;152:1905–9. - PubMed
-
- Prorok P. The National Cancer Institute Multi-Screening Trial. Can J Oncol. 1994;4(suppl 1):98–101. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous